Pharma Capsules - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharma Capsules
Brief pharmaceutical news items for April 2008.

Pharmaceutical Technology

Hunt to Build Plant for Gaylord

Gaylord Chemical (Slidell, LA) and Hunt Refining (Tuscaloosa, AL) signed a long-term exclusive manufacturing and licensing agreement. Hunt Refining will build and operate a 50,000,000-lb dimethyl sulfide (DMS) plant at its Tuscaloosa site using Gaylord's DMS production technology. The plant will supply DMS exclusively to Gaylord, thus providing them with the largest DMS capacity in the world, according to the companies. Construction is expected to be completed in mid-2010.

In addition, Gaylord Chemical will be expanding and relocating its dimethyl sulfoxide production to a site adjacent to the DMS production facility in Tuscaloosa. This relocation will occur in late 2010.

FDA Approves Vetter Production

The US Food and Drug Administration granted Vetter Pharma-Fertigung (Ravensburg, Germany) approval for the production of a new client drug. Vetter, which provides contract manufacturing services for pharmaceutical and biotechnology companies, will begin filling the new drug at its Ravensburg Vetter South facility. The company says the latest FDA client product approval demonstrates its competence in producing aseptically prefilled injection systems for the production of biotechnological and complex medications.

US Pharmacopeia Inaugurates New Headquarters

The US Pharmacopeia (USP, Rockville, MD) held an official grand-opening celebration for its new global headquarters in Rockville. The new site boasts a 141,000-ft2 office building that houses three laboratories. A separate 16,000-ft2 meeting center contains a 273-seat auditorium, five meeting rooms, and a training center.

"USP's new state-of-the-art headquarters facilities allow us to stay at the forefront of science, with new and advanced laboratory operations," said Roger L. Williams, USP's executive vice-president and CEO. "The new meeting center will help us continue to bring together the top scientific and medical experts from around the world to set the highest quality standards for pharmaceuticals and food ingredients."

Xcelience Adds to Its Capabilities

Xcelience (Tampa, FL) became the first contract research organization in North America to purchase Capsugel's "Xcelodose 600 S" precision powder microdoser and automated encapsulator.

The unit fills at speeds higher than 600 capsules/h at 50% greater throughput than its predecessor, the "Xcelodose 600." The new machine is expected to debut at Xcelience as early as May 2008.

Xcelience has grown since its inception and continues to expand its capacity. "Adding to Xcelience's arsenal of tools for assisting our clients to accelerate their early drug development pipelines is paramount to our strategic philosophy," says Randall Guthrie, Xcelience's vice-president.

Ross Opens Indian Factory

Ross's facility in Pune, India.
Charles Ross and Son (Hauppauge, NY) opened a new manufacturing plant in Pune, India. The plant is a 100%-owned facility located 150 km from Mumbai. Ross's Regional Manager Lokendra Singh oversees the operation of this new plant.

Ross initially will manufacture dry-solids blenders and high-shear mixers at the site. The company expects to expand the facility and add new product lines within the next 12 months. Products manufactured at the facility are initially being marketed in India, Southern Asia, Central Asia, and the Middle East but are available to worldwide markets.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here